Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-α

Digestive Diseases and Sciences

Volumn 39, Issue 11, 1994, Pages 2485-2496

  Quiroga, Juan Antonio ^a   Martin, Julio ^a   Pardo, Margarita ^a   Carreño, Vicente ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

chronic hepatitis C; interferon therapy; pathogenesis; soluble immune factors

Indexed keywords

ALPHA INTERFERON; BETA 2 MICROGLOBULIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; NEOPTERIN; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ALPHA2C INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; BIOPTERIN; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; NEOPTERIN; SOLUBILITY;

EID: 0028143968     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF02087671     Document Type: Article

References (30)

1. Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features
2. Long-term clinical and histological follow-up of chronic posttransfusion hepatitis
3. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
4. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis
5. Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B
6. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study
7. Effects of cytokines on the liver
8. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (part I)
9. Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
10. Elevated soluble CD4 levels in human immunodeficiency virus infection
11. Serum soluble CD8 molecule is a marker of CD8 T cell activation in HIV-1 disease
12. The 2-5A system: 2-5A synthetases, isospecies and functions
13. High doses of recombinant alpha interferon or gamma interferon for chronic hepatitis C: A randomized controlled trial
14. Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group
15. An escalating dose regime of recombinant interferon-alpha 2a in the treatment of chronic hepatitis C
16. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
17. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease
18. Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease
19. Reduced production of immunoreactive interleukin-1 by peripheral blood monocytes of patients with acute and chronic viral hepatitis
20. Comparative study of clinical, histological and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis
21. Lymphocyte subsets and β2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment
22. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis
23. Soluble interleukin 2 receptors in acute viral hepatitis and chronic viral disease
24. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1
25. Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and asymptomatic jaundice
26. Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with chronic active liver disease
27. Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry
28. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
29. Elevation of 2′,5′-oligoadenylate synthetase activity and HLA-I associated β2-microglobulin in response to recombinant interferon gamma administration in chronic HBeAg positive hepatitis